Zhejiang Shengzhao Pharmaceutical Technology

Zhejiang Shengzhao Pharmaceutical Technology is a specialized biopharmaceutical company focused on the development and commercialization of complex drug delivery systems, particularly long-acting sustained-release injections. The company leverages high-barrier technology platforms including microspheres, liposomes, and nanocrystals to create improved versions of existing therapies. Its primary therapeutic focus areas include central nervous system disorders, endocrinology, and oncology. Shengzhao operates integrated R&D and manufacturing facilities in China designed to meet global quality standards, aiming to address unmet clinical needs through enhanced drug stability and patient compliance.